Estadístiques de Association of tumor mutational burden and PD-L1 with the efficacy of pembrolizumab with or without chemotherapy versus chemotherapy in advanced urothelial carcinoma
Visites totals
| views | |
|---|---|
| Association of tumor mutational burden and PD-L1 with the efficacy of pembrolizumab with or without chemotherapy versus chemotherapy in advanced urothelial carcinoma | 7 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 7 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Flechon_ccr_asso.pdf | 31 |
| Flechon_ccr_asso.pdf | 3 |